了解加勒-1在心力衰竭中的作用:综合叙事综述
Mohammad Javad Sotoudeheian1, Seyed-Mohamad-Sadegh Mirahmadi2, Mohammad Pirhayati2
1Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Current cardiology reviews
|January 9, 2024
概括
加勒-1 (Gal-1) 是心力衰竭 (HF) 的潜在媒介. 升高的Gal-1水平与高血压发病率,腹功能障碍和生存率降低相关,这表明它是治疗目标.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 分子医学是分子医学.
背景情况:
- 心力衰竭 (HF) 是一个快速增长的全球心血管疾病.
- 炎症和高水平的促炎细胞因子与HF的发展有关.
- 加勒-1 (Gal-1) 是一种莱克,与免疫细胞功能和炎症有关.
研究的目的:
- 调查加勒-1 (Gal-1) 作为心力衰竭 (HF) 中潜在的调解者和生物标志物的作用.
- 探索Gal-1水平与心脏功能障碍之间的关联,包括腹功能障碍和喷射分数.
主要方法:
- 在人类和小鼠模型中分析了加勒-1 (Gal-1) 表达及其与心脏参数的相关性.
- 评估Gal-1水平与心力衰竭发病率,腹筋功能障碍和生存终点相关的评估.
- 对Gal-1和CRP度与喷射分数的评估.
主要成果:
- 加勒-1 (Gal-1) 被确定为心力衰竭 (HF) 在小鼠和人类的潜在媒介.
- 血清Gal-1水平升高与HF发病率增加和腹功能障碍显著相关.
- 较高的Gal-1水平与最低的累积存活率和射出分数的负相关性有关.
结论:
- 加勒-1 (Gal-1) 是一个重要的潜在生物标志物和心力衰竭 (HF) 中介.
- -1-放松调节,特别是在病理性心脏缩中,建议它作为治疗点.
- 对Gal-1作用的进一步研究可能会导致HF的新型诊断和治疗策略.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
01:22Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:05Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K